Type 2 diabetes medications, such as sulfonylureas, have been a mainstay of treating the disease since they came on the ...
Mounjaro shows promise for young patients with Type 2 diabetes and obesity. A recent study reveals its active ingredient, ...
A new drug for treating Type 2 diabetes is on the market this week. Tirzepatide is a once-a-week injection patients can take at home, and researchers are now looking into its applications for weight ...
New research has shown that a common drug used to manage type 2 diabetes could also have anti-aging effects. Henagliflozin is ...
September 11, 2008 (Rome, Italy) — Lifestyle changes, not drugs, should be the main focus for preventing type 2 diabetes: that was the conclusion of a lively debate here at the European Association ...
GLP-1 receptor agonists may reduce the likelihood of mortality and increase odds for transplant wait-listing for patients ...
Black patients twice as likely to have diabetes, yet underrepresented in drug trials for the disease
While black people have one of the highest rates of type 2 diabetes in the country, this population is largely underrepresented in drug trials exploring new treatments for the condition, according to ...
The use of drugs like Ozempic, Wegovy and Zepbound in people with type 1 diabetes has risen sharply over the past decade, a new study finds, even though there’s little information on the drugs’ safety ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results